|
NIH Reapproves WiCell’s H9 and Three Other Wisconsin Stem Cell Lines for Use in Federally Funded Research |
|
April 27, 2010
MADISON, Wis. – Today the National Institutes of Health reapproved the WiCell Research Institute’s H9 (WA09) human embryonic stem (ES) cell line, the most used and cited in scientific research, for ongoing use in federally funded research. It also reapproved three of the other original “Wisconsin” lines, H7 (WA07), H13 (WA13) and H14 (WA14). These four Bush-era lines along with WiCell’s H1 (WA01), which was reapproved by the NIH in January, date to the 1998 discovery of these unique and revolutionary cells in the University of Wisconsin-Madison lab of Dr. James Thomson. They have been used in hundreds of federal research projects, as allowed under the Bush administration, since 2001.
|
|
Read more...
|